Q4 2025 EverGen Infrastructure Corp Earnings Call
Speaker #1: Welcome to the EverGen Infrastructure Fourth Quarter year-end in 2025 earnings results presentation. During the presentation, all participants will be listen-only mode. Participants can submit questions via the Q&A box at the bottom of the screen.
Speaker #1: To be answered following the presentation. As a reminder, this call is being recorded. Before we begin, I would like to direct all participants to our website at www.evergeninfrastructure.com, where you will find a copy of the Fourth Quarter 2025 earnings presentation.
Speaker #1: Please allow me to remind you that our discussion today contains forward-looking statements. Actual results may vary materially from results. Additional information is contained in the Fourth Quarter 2025 management discussion analysis.
Speaker #1: I will now turn the call over to Chase Agile. EverGen Chief Executive Officer to begin.
Speaker #2: Welcome, everyone. Thank you for joining our Q4 and 2025 year-end call. For EverGen 2025, Merck had a period of transition. Following the recapitalization transaction that occurred in May 2025, our focus for the remainder of the year as a management team was on completing our refinancing and stabilizing the business, optimizing our existing assets by putting in place lasting, sustainable operating systems and culture as a part of a platform reset.
Speaker #2: And starting to look ahead to the future for growth. In terms of the platform reset, our focus is really on driving discipline optimization across our team, our people, our assets, and our systems, and I think kudos to our operating team and the people in our business.
Speaker #2: We started to see the fruits of those labors, and I think Q4. We began to see those benefits from the turnaround and the optimization initiatives take hold in the form of record R&D production, improved operating performance, and across our R&D assets.
Speaker #2: And in terms of financial results, which Maria will touch on here next, our goal is to build a stabilized platform that has resilient EBITDA tied to 20-year contracts with our operating partners.
Speaker #2: And ultimately, building a very strong infrastructure foundation for growing EverGen into our future assets and being able to do that on a repeatable basis in 2026 and beyond.
Speaker #2: So with that alternative over before we get to that, I guess maybe we'll start with just a corporate snapshot here. We'll go back just to see where we're at today for those that maybe weren't following the recapitalization transaction.
Speaker #2: We so with the recapitalization, there was a $5 million investment made in May 2025. Following that transaction and following a subsequent financing that was completed in January, management and board now hold 41% of the company's shares and are lined for long-term shareholder value creation with 31% additional shareholder base coming from pensions and institutional shareholders and other family offices.
Speaker #2: So together, we see it as a very aligned business, very different from a lot of other publicly listed companies. From a market cap standpoint, we currently have a market cap of approximately $10.2 million.
Speaker #2: Now, I think it's worth pointing out, we completed our second tranche of the total $7 million that was put into the business over the last 12 months, in January, at a fair price of $0.60.
Speaker #2: That is where we since board management and shareholders have come into the company at. In terms of private placement pricing. Where we stand from an asset perspective in terms of debt perspective or debt load perspective, that is primarily held at the asset level now.
Speaker #2: We completed in January a transaction with Farm Credit Canada to take our corporate debt and de-leverage the corporate level and bring that debt down to a more attractive facility with Farm Credit Canada that's primarily tied to Fraser Valley Biogas.
Speaker #2: So that was a huge lift by our team, by Maria, and by a supporting team in our finance group. And ultimately, it gives EverGen the flexibility to finance projects as it goes forward, as it sees fit, but also operational flexibility day to day.
Speaker #2: So with that, I'll turn it over to Maria to walk through our Q4 in 2025 results.
Speaker #1: Thanks, Chase. I'm excited for joining us again for the Q4 and year-end earnings call. As Chase has already alluded to, the fourth quarter in the fourth quarter, we delivered our strongest quarter of 2025, largely driven by our record revenue production and also carbon credit revenue realized in the quarter.
Speaker #1: Making this the fourth consecutive quarter record R&D production since the recapitalization in May 2025. We also completed a construction of the PCR screening building during the quarter as well.
Speaker #1: Turning to the numbers, so first of all, for revenue for Q4 2025, these increased 34% compared to Q4 of the prior year, reading 4.2 million.
Speaker #1: This was primarily driven by strong carbon credit sales of 1.2 million in the quarter, compared to sales in Q4 2024, as well as continued R&D production growth at Fraser Valley Biogas and PROTAC, which saw R&D revenues increase 35% year on year.
Speaker #1: The full year did see a decrease of revenue to 11.7 million for 2025. This primarily reflects the decreased tipping volumes at received at the organic waste composting facilities in the first nine months of the year.
Speaker #1: And due to the project's slight cleanup and asset optimization activities, these were also outset by increased R&D production and carbon credit revenues. Compared to Q3 2025, again, there was an increase across revenue from 2.8 million or sorry, decrease in revenues was driven by carbon credit sales again recognized in the quarter, and again, the R&D reduction growth.
Speaker #1: Turning to adjusted EBITDA and this came at 1.3 million for Q4 2025, which is a 1.2 million increase when compared to Q4 2024. Largely driven by the already mentioned supplier revenues and some lower direct operating costs.
Speaker #1: For the full year of 2025, adjusted EBITDA sat at 2.5 million, compared to 2.9 million in 2004. So a slight decrease here, but generally positive despite having lower tipping revenues and due to lower volumes at the composting sites for the first nine months of the year.
Speaker #1: And then some higher G&A costs. These were partially offset by those favorable carbon credit sales in the year, and a reduction in some direct operating costs.
Speaker #1: When compared to prior quarter, we saw an increase in adjusted EBITDA of 0.8 million. Again, largely due to the favorable revenues combined with those slightly lower direct operating costs.
Speaker #1: On the balance sheet, our liquidity position has improved during 2025. Subsequent to year-end, and as Chase has already mentioned, in January 2026, we formally closed the previously announced $13 million asset-level debt facility at Fraser Valley Biogas.
Speaker #1: And we repaid the majority of the corporate level term loan. And we also closed out on the second tranche of the private placement for gross proceeds of approximately $1.9 million.
Speaker #1: Together with these transactions, the balance sheet has seen a strengthening, and it provides a strong foundation as we move through into 2026. The results for the quarter especially and the improvements throughout the year reflect the progress that the new management team has made in stabilizing and optimizing our core asset base.
Speaker #1: And we believe that everything is in a good position to improve and stabilize EBITDA for the rest of the year. And with that, I'll turn it back to Chase to continue with our earnings presentation.
Speaker #2: Great. Thank you, Maria. Well said. I think subsequent to the quarter end, we've press released a couple of transformational deals that were really important for balance sheet health.
Speaker #2: I think where we stand now with the previously mentioned debt facility closed with Farm Credit Canada is we've got healthy and right-sized balance sheets in terms of the equity that was invested and we closed the second tranche at 60% private placement, about 1.9 million of proceeds as well in January.
Speaker #2: And we entered into the 20-year term with Fortis on our off-seat agreement at Fraser Valley. So that agreement took effect. Those three things really have put in place a stable financial position for the business and will continue to see increased revenue from our R&D sales through that uptake agreement.
Operator: Welcome to the EverGen Infrastructure Q4 year-end and 2025 Earnings Results Presentation. During the presentation, all participants will be in a listen-only mode. Participants can submit questions via the Q&A box at the bottom of the screen, which will be answered following the presentation. As a reminder, this call is being recorded. Before we begin, I would like to direct all participants to our website at www.evergeninfra.com, where you will find a copy of the Q4 2025 earnings presentation. Please allow me to remind you that our discussion today contains forward-looking statements. Actual results may vary materially from results. Additional information is contained in the Q4 2025 management discussion analysis. I will now turn the call over to Chase Edgelow, EverGen's Chief Executive Officer, to begin.
Operator: Welcome to the EverGen Infrastructure Q4 year-end and 2025 earnings results presentation. During the presentation, all participants will be in a listen-only mode. Participants can submit questions via the Q&A box at the bottom of the screen, which will be answered following the presentation. As a reminder, this call is being recorded. Before we begin, I would like to direct all participants to our website at www.evergeninfra.com, where you will find a copy of the Q4 2025 earnings presentation. Please allow me to remind you that our discussion today contains forward-looking statements. Actual results may vary materially from results. Additional information is contained in the Q4 2025 management discussion analysis. I will now turn the call over to Chase Edgelow, EverGen's Chief Executive Officer, to begin.
Speaker #2: Let me go to the next slide. Where we stand today versus where the company has come from—I think it's important to see here, maybe it looks like a small change on this chart, from pulling 150,000 gigajoules in 2024 to 200,000.
Speaker #2: But what that really represents is our facility's operating much closer to their capacity and therefore increased EBITDA margins. So when we're operating at 70% at an R&D facility, we are covering costs.
Chase Edgelow: Welcome, everyone, and thank you for joining our Q4 and 2025 year-end call. For EverGen, 2025 marked a period of transition. Following the recapitalization transaction that occurred in May 2025, our focus for the remainder of the year as a management team was on completing our refinancing and stabilizing the business, optimizing our existing assets by putting in place lasting, sustainable operating systems and culture as a part of a platform reset, starting to look ahead to the future for growth. In terms of the platform reset, our focus is really on driving disciplined optimization across our team, our people, our assets, and our systems. I think, kudos to our operating team and the people in our business. We started to see the fruits of those labors, I think, in Q4.
Chase Edgelow: Welcome, everyone, and thank you for joining our Q4 and 2025 year-end call. For EverGen, 2025 marked a period of transition. Following the recapitalization transaction that occurred in May 2025, our focus for the remainder of the year as a management team was on completing our refinancing and stabilizing the business, optimizing our existing assets by putting in place lasting, sustainable operating systems and culture as a part of a platform reset, starting to look ahead to the future for growth. In terms of the platform reset, our focus is really on driving disciplined optimization across our team, our people, our assets, and our systems. I think, kudos to our operating team and the people in our business. We started to see the fruits of those labors, I think, in Q4.
Speaker #2: We are making a little bit of money. When we're operating at 100% of nameplate capacity, that's when we start to see the real torque in the generation.
Speaker #2: I think the other thing to note here is that we've started to rebuild our growth pipeline. We have a number of projects that would be organic growth.
Speaker #2: So adding on to our existing assets, across the portfolio, so the Pacific Coast Renewables project, that we completed the screening building on. We are preparing for an updated and renewed FID on that project.
Speaker #2: We have been working on all of the key tenets of project development to be ready to make that decision. But I think most notably, we continue to advance the permitting on that project, which has been a major delay for the business in terms of investing that capital.
Chase Edgelow: We began to see those benefits from the turnaround and the optimization initiatives take hold in the form of record RNG production, improved operating performance, across RNG assets, and in terms of financial results, which Maria will touch on here next. Our goal is to build a stabilized platform that has resilient EBITDA tied to 20-year contracts with our offtake partners. Ultimately building a very strong infrastructure foundation for growing EverGen into our future assets and being able to do that on a repeatable basis in 2026 and beyond. With that, I'll turn it over. Before we get to that, I guess maybe we'll start with just a corporate snapshot here. We'll go back just to say where we're at today for those that maybe weren't following the recapitalization transaction.
Chase Edgelow: We began to see those benefits from the turnaround and the optimization initiatives take hold in the form of record RNG production, improved operating performance, across RNG assets, and in terms of financial results, which Maria will touch on here next. Our goal is to build a stabilized platform that has resilient EBITDA tied to 20-year contracts with our offtake partners. Ultimately building a very strong infrastructure foundation for growing EverGen into our future assets and being able to do that on a repeatable basis in 2026 and beyond. With that, I'll turn it over. Before we get to that, I guess maybe we'll start with just a corporate snapshot here. We'll go back just to say where we're at today for those that maybe weren't following the recapitalization transaction.
Speaker #2: That R&D expansion at Pacific Coast Renewables would add about 100,000 gigajoules. Then across the portfolio growth tech, growth tech has a number of different expansion options that we're reviewing at this time.
Speaker #2: Our goal is to take that facility to 120,000-plus gigajoules from around 70,000 today. So an addition of about 50,000 gigajoules. On top of this space, and then lastly, I'll mention project radius in Ontario.
Speaker #2: There are it continues to be an important project development work that's done on that project, and we expect to be able to announce and talk about that in the near future.
Speaker #2: With when we look across the portfolio, I think the other thing to note is that at Fraser Valley Biogas, this is the template for the organic growth that we talk about in our portfolio.
Chase Edgelow: With the recapitalization, there was a CAD 5 million investment made in May 2025. Following that transaction and following the subsequent financing that was completed in January, management and board now hold 41% of the company shares and are aligned for long-term shareholder value creation, with 31% additional shareholder base coming from pensions, institutional shareholders, and other family offices. Together, we see it as a very aligned business, very different from a lot of other publicly listed companies. From a market cap standpoint, we currently have a market cap of approximately CAD 10.2 million.
Chase Edgelow: With the recapitalization, there was a CAD 5 million investment made in May 2025. Following that transaction and following the subsequent financing that was completed in January, management and board now hold 41% of the company shares and are aligned for long-term shareholder value creation, with 31% additional shareholder base coming from pensions, institutional shareholders, and other family offices. Together, we see it as a very aligned business, very different from a lot of other publicly listed companies. From a market cap standpoint, we currently have a market cap of approximately CAD 10.2 million.
Speaker #2: So what we did at Fraser Valley—we invested approximately $12 million in R&D expansion. We now have what we see, through our COO Ron Green, as a repeatable operating philosophy, including systems, with critical spares being something that we have budgeted for.
Speaker #2: And seeing the fruits of those labors, Fraser Valley Biogas is operating close to 97% uptime, which we believe is best in class in R&D space.
Speaker #2: And really speaks to where EverGen's a little bit different. Our goal here is that we sit in the intersection of waste processing and renewable energy production.
Chase Edgelow: I think worth pointing out, we completed our second tranche of the total CAD 7 million that was put into the business over the last 12 months in January at a share price of CAD 0.60, and that is where recent board management and shareholders have come into the company at in terms of private placement pricing. Where we stand from an asset perspective in terms of debt perspective or debt load perspective, that is primarily held at the asset level now. We completed in January a transaction with Farm Credit Canada to take our corporate debt and de-lever it at the corporate level and bring that debt down to a more attractive facility with Farm Credit Canada, that's primarily tied to Fraser Valley Biogas.
Chase Edgelow: I think worth pointing out, we completed our second tranche of the total CAD 7 million that was put into the business over the last 12 months in January at a share price of CAD 0.60, and that is where recent board management and shareholders have come into the company at in terms of private placement pricing. Where we stand from an asset perspective in terms of debt perspective or debt load perspective, that is primarily held at the asset level now. We completed in January a transaction with Farm Credit Canada to take our corporate debt and de-lever it at the corporate level and bring that debt down to a more attractive facility with Farm Credit Canada, that's primarily tied to Fraser Valley Biogas.
Speaker #2: And we want to bring the best of Canada's long history as an energy producer into a smaller, more fragmented market in the R&D space.
Speaker #2: I think we've been able to do that. A lot of our team comes from a metal and gas background, and applying those same skills—on a smaller scale, but on a higher-value scale in terms of the price that we get paid for our gas—is turning out to be a successful formula.
Speaker #2: Growth tech, similar, in terms of we've been able to apply a lot of the learnings at Fraser Valley Biogas into the growth tech asset and see an uptime increase in across the board.
Speaker #2: And the same operating philosophy will be applied to Pacific Coast as we move into the our expansion project there. So what's in store for the future?
Chase Edgelow: That was, you know, that was a huge lift by our team, by Maria, and by the supporting team, in our finance group, and ultimately gives EverGen the flexibility to finance projects as it goes forward, as it sees fit, but also operational flexibility day-to-day. With that, I'll turn it over to Maria to walk through our Q4 and 2025 results.
Chase Edgelow: That was, you know, that was a huge lift by our team, by Maria, and by the supporting team, in our finance group, and ultimately gives EverGen the flexibility to finance projects as it goes forward, as it sees fit, but also operational flexibility day-to-day. With that, I'll turn it over to Maria to walk through our Q4 and 2025 results.
Speaker #2: And then I think we'll turn it over for questions. I think what you've seen from us in the last almost 12 months is a real focus on cleaning up our balance sheet, underpinning our performance with strong operations.
Speaker #2: And the very early stages of building out both organic growth and inorganic growth opportunities. So building a pipeline of projects that we can operate and that we can develop and we can do in a formulaic way that's repeatable and where we've got the trust of counterparties in the business.
Maria O'Sullivan: Thanks, Chase. And thank everyone for joining us again for the Q4 and year-end earnings call. As Chase has already alluded to, in Q4, we delivered our strongest quarter of 2025, largely driven by our record RNG production and also carbon credit revenue realized in the quarter, making this the fourth consecutive quarter of record RNG production since the recapitalization in May 2025. We also completed construction of the PCR screening building during the quarter as well. Turning to the numbers. First of all, for revenue for Q4 2025, we've increased 34% compared to Q4 of the prior year, reaching CAD 4.2 million.
Maria: Thanks, Chase. And thank everyone for joining us again for the Q4 and year-end earnings call. As Chase has already alluded to, in Q4, we delivered our strongest quarter of 2025, largely driven by our record RNG production and also carbon credit revenue realized in the quarter, making this the fourth consecutive quarter of record RNG production since the recapitalization in May 2025. We also completed construction of the PCR screening building during the quarter as well. Turning to the numbers. First of all, for revenue for Q4 2025, we've increased 34% compared to Q4 of the prior year, reaching CAD 4.2 million.
Speaker #2: So I think looking forward, look forward a PCR R&D expansion announcement coming from us. Look forward project radius, continued development there, and look forward other organic and inorganic growth opportunities coming to bear for the company.
Maria O'Sullivan: This is primarily driven by strong carbon credit sales of CAD 1.2 million in the quarter compared to nil in Q4 2024, as well as continued RNG production growth at Fraser Valley Biogas and GrowTEC, which saw RNG revenues increase 35% year on year. The full year did see a decrease of revenue to CAD 11.7 million for 2025. This primarily reflects the decreased tipping volumes received at the organic and waste composting facilities in the first nine months of the year due to those project site cleanup and asset optimization activities. These were also offset by increased RNG collection and carbon credit revenues. Compared to Q3 2025, again, there was a decrease in revenues.
Maria: This is primarily driven by strong carbon credit sales of CAD 1.2 million in the quarter compared to nil in Q4 2024, as well as continued RNG production growth at Fraser Valley Biogas and GrowTEC, which saw RNG revenues increase 35% year on year. The full year did see a decrease of revenue to CAD 11.7 million for 2025. This primarily reflects the decreased tipping volumes received at the organic and waste composting facilities in the first nine months of the year due to those project site cleanup and asset optimization activities. These were also offset by increased RNG collection and carbon credit revenues. Compared to Q3 2025, again, there was a decrease in revenues.
Maria: This was driven by carbon credit sales again recognized and recorded, the RNG production growth. Turning to adjusted EBITDA, this came in at CAD 1.3 million for Q4 2025, which is a CAD 1.2 million increase when compared to Q4 2024, largely driven by the already mentioned and discussed higher revenues and some lower direct operating costs. For the full year of 2025, adjusted EBITDA was at CAD 2.5 million compared to CAD 2.9 million in 2004. A slight decrease here, generally positive, despite having lower tipping revenues, due to those lower volumes at the composting sites for the first 9 months of the year. Some higher G&A costs.
Maria O'Sullivan: This was driven by carbon credit sales again recognized and recorded, the RNG production growth. Turning to adjusted EBITDA, this came in at CAD 1.3 million for Q4 2025, which is a CAD 1.2 million increase when compared to Q4 2024, largely driven by the already mentioned and discussed higher revenues and some lower direct operating costs. For the full year of 2025, adjusted EBITDA was at CAD 2.5 million compared to CAD 2.9 million in 2004. A slight decrease here, generally positive, despite having lower tipping revenues, due to those lower volumes at the composting sites for the first 9 months of the year. Some higher G&A costs.
Maria: These were partially offset by those favorable carbon credit sales in the year and a reduction in some direct operating costs. When compared to the prior quarter, we saw an increase in adjusted EBITDA of CAD 0.8 million. Again, largely due to the favorable revenues, combined with those slightly lower direct operating costs. On the balance sheet, our liquidity position has improved during 2025. Subsequent to year-end, and as Chase has already mentioned, in January 2026, we formally closed the previously announced CAD 13 million asset level debt facility at Fraser Valley Biogas, and we repaid the majority of the corporate level term loan. We also closed out on the second tranche of the private placement for gross proceeds of approximately CAD 1.9 million.
Maria O'Sullivan: These were partially offset by those favorable carbon credit sales in the year and a reduction in some direct operating costs. When compared to the prior quarter, we saw an increase in adjusted EBITDA of CAD 0.8 million. Again, largely due to the favorable revenues, combined with those slightly lower direct operating costs. On the balance sheet, our liquidity position has improved during 2025. Subsequent to year-end, and as Chase has already mentioned, in January 2026, we formally closed the previously announced CAD 13 million asset level debt facility at Fraser Valley Biogas, and we repaid the majority of the corporate level term loan. We also closed out on the second tranche of the private placement for gross proceeds of approximately CAD 1.9 million.
Maria: Together with these transactions, the balance sheet has seen a strengthening, and it provides a strong foundation as we move through into 2026. The results for the quarter, especially, and the improvements throughout the year reflect the progress that the new management team has made in stabilizing and optimizing our core asset base. We believe that EverGen is in a great position to improve and stabilize EBITDA for the rest of the year. With that, I'll turn it back to Chase to continue with the earnings presentation.
Maria O'Sullivan: Together with these transactions, the balance sheet has seen a strengthening, and it provides a strong foundation as we move through into 2026. The results for the quarter, especially, and the improvements throughout the year reflect the progress that the new management team has made in stabilizing and optimizing our core asset base. We believe that EverGen is in a great position to improve and stabilize EBITDA for the rest of the year. With that, I'll turn it back to Chase to continue with the earnings presentation.
Chase Edgelow: Great. Thank you, Maria. Well said. I think, you know, subsequent to the quarter end, we've, you know, we've press released a couple of transformational deals that were really important for balance sheet health. I think, you know, where we stand now with the previously mentioned debt facility closed with Farm Credit Canada is we've got a healthy and right-sized balance sheet in terms of the equity that was invested. We closed the second tranche of the CAD 0.60 private placement for about CAD 1.9 million of proceeds as well in January. We entered into the 20-year term with FortisBC on our offtake agreement at Fraser Valley, so that agreement took effect.
Chase Edgelow: Great. Thank you, Maria. Well said. I think, you know, subsequent to the quarter end, we've, you know, we've press released a couple of transformational deals that were really important for balance sheet health. I think, you know, where we stand now with the previously mentioned debt facility closed with Farm Credit Canada is we've got a healthy and right-sized balance sheet in terms of the equity that was invested. We closed the second tranche of the CAD 0.60 private placement for about CAD 1.9 million of proceeds as well in January. We entered into the 20-year term with FortisBC on our offtake agreement at Fraser Valley, so that agreement took effect.
Chase Edgelow: You know, those three things really have put in place a stable financial position for the business, and we will continue to see increased revenue from RNG sales through that offtake agreement. Can we go to the next slide? You know, where we stand today versus where the company is coming from, I think is important to see here. Maybe it looks like a small change on this chart from, you know, call it 150,000 gigajoules in 2024 to 200,000. What that really represents is our facilities operating much closer to their capacity and therefore, increased EBITDA margins. You know, when we're operating at 70% at an RNG facility, we are covering costs. We are making a little bit of money.
Chase Edgelow: You know, those three things really have put in place a stable financial position for the business, and we will continue to see increased revenue from RNG sales through that offtake agreement. Can we go to the next slide? You know, where we stand today versus where the company is coming from, I think is important to see here. Maybe it looks like a small change on this chart from, you know, call it 150,000 gigajoules in 2024 to 200,000. What that really represents is our facilities operating much closer to their capacity and therefore, increased EBITDA margins. You know, when we're operating at 70% at an RNG facility, we are covering costs. We are making a little bit of money.
Chase Edgelow: When we're operating at 100% of nameplate capacity, that's when we start to see the real torque in the EBITDA generation. I think the other thing to note here is that we've, you know, we've started to rebuild our growth pipeline. We have a number of projects that would be organic growth, so adding on to our existing assets across the portfolio. The Pacific Coast Renewables project that we completed the screening building on. We are preparing for an updated and renewed FID on that project. We have been working on all of the key tenements of project development to be ready to make that decision. I think most notably, we continue to advance the permitting on that project, which has been the major delay for the business in terms of investing that capital.
Chase Edgelow: When we're operating at 100% of nameplate capacity, that's when we start to see the real torque in the EBITDA generation. I think the other thing to note here is that we've, you know, we've started to rebuild our growth pipeline. We have a number of projects that would be organic growth, so adding on to our existing assets across the portfolio. The Pacific Coast Renewables project that we completed the screening building on. We are preparing for an updated and renewed FID on that project. We have been working on all of the key tenements of project development to be ready to make that decision. I think most notably, we continue to advance the permitting on that project, which has been the major delay for the business in terms of investing that capital.
Chase Edgelow: That RNG expansion at Pacific Coast Renewables would add about 100,000 gigajoules. Across the portfolio, GrowTEC. GrowTEC has a number of different expansion options that we're reviewing at this time. You know, our goal is to take that facility to 120,000 plus gigajoules from around 70,000 today. An addition of about 50,000 gigajoules on top of this base. Lastly, I'll mention Project Radius in Ontario. There are, this continues to be important project development work that's done on that project, and we expect to be able to announce and talk about that in the near future.
Chase Edgelow: That RNG expansion at Pacific Coast Renewables would add about 100,000 gigajoules. Across the portfolio, GrowTEC. GrowTEC has a number of different expansion options that we're reviewing at this time. You know, our goal is to take that facility to 120,000 plus gigajoules from around 70,000 today. An addition of about 50,000 gigajoules on top of this base. Lastly, I'll mention Project Radius in Ontario. There are, this continues to be important project development work that's done on that project, and we expect to be able to announce and talk about that in the near future.
Chase Edgelow: You know, when we look across the portfolio, I think the other, you know, the other thing to note is that at Fraser Valley Biogas, this is, you know, this is the template for the organic growth that we talk about in our portfolio. What we did at Fraser Valley, where we invested approximately CAD 12 million in our RNG expansion. We now have what we see through our COO, Ron Green, as a repeatable operating philosophy, including systems, including critical spares being, you know, being something that we have budget for, and seeing the fruits of those labors. Fraser Valley Biogas is operating at close to 97% uptime, which we believe is best in class in the RNG space and really speaks to where EverGen's a little bit different.
Chase Edgelow: You know, when we look across the portfolio, I think the other, you know, the other thing to note is that at Fraser Valley Biogas, this is, you know, this is the template for the organic growth that we talk about in our portfolio. What we did at Fraser Valley, where we invested approximately CAD 12 million in our RNG expansion. We now have what we see through our COO, Ron Green, as a repeatable operating philosophy, including systems, including critical spares being, you know, being something that we have budget for, and seeing the fruits of those labors. Fraser Valley Biogas is operating at close to 97% uptime, which we believe is best in class in the RNG space and really speaks to where EverGen's a little bit different.
Chase Edgelow: You know, our, you know, our goal here is that we sit in the intersection of waste processing and renewable energy production, and we want to bring the best of Canada's long history as a, as an energy producer into a smaller, more fragmented market in the RNG space. I think we've been able to do that. A lot of our team comes from an oil and gas background and applying those same skills to, on a smaller scale, but on a, you know, a higher value scale in terms of the price that we get paid for our gas, is turning out to, you know, be a successful formula. GrowTEC, similar in terms of we've been able to apply a lot of the learnings at Fraser Valley Biogas into the GrowTEC asset and seen uptime increase in across the board.
Chase Edgelow: You know, our, you know, our goal here is that we sit in the intersection of waste processing and renewable energy production, and we want to bring the best of Canada's long history as a, as an energy producer into a smaller, more fragmented market in the RNG space. I think we've been able to do that. A lot of our team comes from an oil and gas background and applying those same skills to, on a smaller scale, but on a, you know, a higher value scale in terms of the price that we get paid for our gas, is turning out to, you know, be a successful formula. GrowTEC, similar in terms of we've been able to apply a lot of the learnings at Fraser Valley Biogas into the GrowTEC asset and seen uptime increase in across the board.
Chase Edgelow: The same operating philosophy will be applied to Pacific Coast Renewables as we move into our expansion project there. What's in store for future? I think we'll turn it over for questions. I think what you've seen from us in the last almost 12 months is a real focus on cleaning up our balance sheet, underpinning our performance with strong operations, and the very early stages of building out both organic growth and inorganic growth opportunities. Building a pipeline of projects that we can operate and that we can develop and that we can do in a formulaic way that's repeatable and where we've got the trust of counterparties in the business. I think looking forward, look for a PCR RNG expansion announcement coming from us.
Chase Edgelow: The same operating philosophy will be applied to Pacific Coast Renewables as we move into our expansion project there. What's in store for future? I think we'll turn it over for questions. I think what you've seen from us in the last almost 12 months is a real focus on cleaning up our balance sheet, underpinning our performance with strong operations, and the very early stages of building out both organic growth and inorganic growth opportunities. Building a pipeline of projects that we can operate and that we can develop and that we can do in a formulaic way that's repeatable and where we've got the trust of counterparties in the business. I think looking forward, look for a PCR RNG expansion announcement coming from us.
Chase Edgelow: Look for Project Radius, continued development there, and look for other organic and inorganic growth opportunities coming to bear for the company.
Chase Edgelow: Look for Project Radius, continued development there, and look for other organic and inorganic growth opportunities coming to bear for the company.
Maria: Thank you very much, Chase.
Maria O'Sullivan: Thank you very much, Chase.
